These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31509724)

  • 1. Immunotherapeutic Approaches for the Treatment of Colorectal Cancer.
    Abakushina EV; Gelm YV; Pasova IA; Bazhin AV
    Biochemistry (Mosc); 2019 Jul; 84(7):720-728. PubMed ID: 31509724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunotherapy for colorectal cancer].
    Tougeron D; Fauquembergue É; Latouche JB
    Bull Cancer; 2013 Sep; 100(9):871-85. PubMed ID: 23917703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy in human colorectal cancer: Challenges and prospective.
    Sun X; Suo J; Yan J
    World J Gastroenterol; 2016 Jul; 22(28):6362-72. PubMed ID: 27605872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experience.
    Correale P; Cusi MG; Micheli L; Nencini C; Del Vecchio MT; Torino F; Aquino A; Bonmassar E; Francini G; Giorgi G
    Invest New Drugs; 2006 Mar; 24(2):99-110. PubMed ID: 16502353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy for colorectal cancer.
    Koido S; Ohkusa T; Homma S; Namiki Y; Takakura K; Saito K; Ito Z; Kobayashi H; Kajihara M; Uchiyama K; Arihiro S; Arakawa H; Okamoto M; Gong J; Tajiri H
    World J Gastroenterol; 2013 Dec; 19(46):8531-42. PubMed ID: 24379570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review on the immunotherapy strategies against metastatic colorectal carcinoma.
    Signorini L; Delbue S; Ferrante P; Bregni M
    Immunotherapy; 2016 Oct; 8(10):1245-61. PubMed ID: 27605072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-1/ PD-L1 blockade as a novel treatment for colorectal cancer.
    Yaghoubi N; Soltani A; Ghazvini K; Hassanian SM; Hashemy SI
    Biomed Pharmacother; 2019 Feb; 110():312-318. PubMed ID: 30522017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy for colorectal cancer.
    Maxwell-Armstrong CA; Durrant LG; Scholefield JH
    Am J Surg; 1999 Apr; 177(4):344-8. PubMed ID: 10326858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expanding role of immunotherapy.
    Martin-Liberal J; Ochoa de Olza M; Hierro C; Gros A; Rodon J; Tabernero J
    Cancer Treat Rev; 2017 Mar; 54():74-86. PubMed ID: 28231560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human vaccines & immunotherapeutics: news.
    Riedmann EM
    Hum Vaccin Immunother; 2013 Jul; 9(7):1395-8. PubMed ID: 23863285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential role of immunotherapy to treat colorectal cancer.
    Amin M; Lockhart AC
    Expert Opin Investig Drugs; 2015 Mar; 24(3):329-44. PubMed ID: 25519074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cancer immunotherapy].
    Kjeldsen JW; Donia M; Svane IM
    Ugeskr Laeger; 2018 May; 180(21):. PubMed ID: 29804567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic therapy of gastrointestinal cancer.
    Tempero M
    Cancer Treat Res; 1998; 98():227-37. PubMed ID: 10326671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Possibilities of immunotherapy of colorectal cancers and pancreatic tumors].
    Klapdor R
    Z Gastroenterol Verh; 1991 Mar; 26():220-7. PubMed ID: 1714155
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of transmembrane glycoprotein mucin 1 (MUC1) in various types of colorectal cancer and therapies: Current research status and updates.
    Guo M; You C; Dou J
    Biomed Pharmacother; 2018 Nov; 107():1318-1325. PubMed ID: 30257347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of cancer immunotherapeutic strategies.
    Wahid B; Ali A; Rafique S; Waqar M; Wasim M; Wahid K; Idrees M
    Immunotherapy; 2018 Aug; 10(11):999-1010. PubMed ID: 30149763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune cells in colorectal cancer: prognostic relevance and therapeutic strategies.
    Atreya I; Neurath MF
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):561-72. PubMed ID: 18402523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy for metastatic colorectal cancer: present status and new options.
    Ellebaek E; Andersen MH; Svane IM; Straten PT
    Scand J Gastroenterol; 2012 Mar; 47(3):315-24. PubMed ID: 22214467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies in cancer immunotherapy.
    Kimiz-Gebologlu I; Gulce-Iz S; Biray-Avci C
    Mol Biol Rep; 2018 Dec; 45(6):2935-2940. PubMed ID: 30311129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy for treating metastatic colorectal cancer.
    Boghossian S; Robinson S; Von Delwig A; Manas D; White S
    Surg Oncol; 2012 Jun; 21(2):67-77. PubMed ID: 21292476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.